Clinical Trial Update: Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating human recombinant interferon gamma for treating ventilator-associated pneumonia in ICU patients; the study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Interferon gamma-1b (Actimmune) (Interferon gamma-1b)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Pneumonia, Ventilator-Associated | Phase 3 | Status: RECRUITING